Barrington Research Weighs in on Option Care Health, Inc.’s Q1 2025 Earnings (NASDAQ:OPCH)

Option Care Health, Inc. (NASDAQ:OPCH) – Barrington Research raised their Q1 2025 earnings per share estimates for Option Care Health in a note issued to investors on Wednesday, April 24th. Barrington Research analyst M. Petusky now anticipates that the company will post earnings per share of $0.30 for the quarter, up from their prior estimate of $0.26. Barrington Research currently has a “Outperform” rating and a $38.00 target price on the stock. The consensus estimate for Option Care Health’s current full-year earnings is $1.17 per share. Barrington Research also issued estimates for Option Care Health’s Q4 2025 earnings at $0.37 EPS and FY2026 earnings at $1.55 EPS.

Separately, Jefferies Financial Group raised their price target on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a report on Monday, March 4th.

Option Care Health Stock Up 1.1 %

Shares of Option Care Health stock opened at $29.61 on Thursday. The company’s 50 day moving average price is $31.96 and its 200-day moving average price is $31.48. Option Care Health has a 52-week low of $24.23 and a 52-week high of $35.74. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.33 and a current ratio of 1.77. The stock has a market capitalization of $5.15 billion, a price-to-earnings ratio of 19.48, a P/E/G ratio of 1.65 and a beta of 1.22.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Tuesday, April 23rd. The company reported $0.26 EPS for the quarter, topping analysts’ consensus estimates of $0.22 by $0.04. Option Care Health had a return on equity of 18.92% and a net margin of 6.15%. The business had revenue of $1.15 billion for the quarter, compared to analysts’ expectations of $1.10 billion. During the same period in the previous year, the firm earned $0.21 EPS. The business’s quarterly revenue was up 12.8% on a year-over-year basis.

Hedge Funds Weigh In On Option Care Health

Hedge funds and other institutional investors have recently modified their holdings of the stock. Vontobel Holding Ltd. grew its holdings in shares of Option Care Health by 2.9% during the 3rd quarter. Vontobel Holding Ltd. now owns 13,168 shares of the company’s stock worth $426,000 after acquiring an additional 374 shares during the period. IFP Advisors Inc grew its stake in Option Care Health by 20,350.0% in the third quarter. IFP Advisors Inc now owns 2,454 shares of the company’s stock worth $79,000 after purchasing an additional 2,442 shares during the period. SG Americas Securities LLC raised its holdings in Option Care Health by 1,638.4% in the third quarter. SG Americas Securities LLC now owns 84,729 shares of the company’s stock worth $2,741,000 after purchasing an additional 79,855 shares in the last quarter. State of Alaska Department of Revenue lifted its position in Option Care Health by 4.3% during the third quarter. State of Alaska Department of Revenue now owns 21,376 shares of the company’s stock valued at $691,000 after buying an additional 880 shares during the period. Finally, Avior Wealth Management LLC lifted its position in Option Care Health by 30.5% during the third quarter. Avior Wealth Management LLC now owns 15,706 shares of the company’s stock valued at $508,000 after buying an additional 3,670 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Insiders Place Their Bets

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 35,000 shares of the firm’s stock in a transaction that occurred on Monday, February 26th. The stock was bought at an average price of $31.55 per share, for a total transaction of $1,104,250.00. Following the completion of the acquisition, the director now directly owns 269,528 shares in the company, valued at $8,503,608.40. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.